Telecommunications Standard JULY 2012
|
|
- Mary O’Neal’
- 6 years ago
- Views:
Transcription
1 Telecommunications Standard
2 Telecommunications Standard Copyright 2012 National Council for Prescription Drug Programs, Inc. This work is owned by National Council for Prescription Drug Programs, Inc., 9240 E. Raintree Drive, Scottsdale, AZ 85260, (480) , and protected by the copyright laws of the United States. 17 U.S.C. 101, et. seq. Permission is given to Council members to copy and use the work or any part thereof in connection with the business purposes of the Council members. The work may not be changed or altered. The work may not be sold, used or exploited for commercial purposes. This permission may be revoked by National Council for Prescription Drug Programs, Inc., at any time. The National Council for Prescription Drugs Programs, Inc. is not responsible for any errors or damage as a result of the use of the work. NCPDP recognizes the confidentiality of certain information exchanged electronically through the use of its standards. Users should be familiar with the federal, state, and local laws, regulations and codes requiring confidentiality of this information and should utilize the standards accordingly. NOTICE: In addition, this NCPDP Standard contains certain data fields and elements that may be completed by users with the proprietary information of third parties. The use and distribution of third parties' proprietary information without such third parties' consent, or the execution of a license or other agreement with such third party, could subject the user to numerous legal claims. All users are encouraged to contact such third parties to determine whether such information is proprietary and if necessary, to consult with legal counsel to make arrangements for the use and distribution of such proprietary information.
3 TELECOMMUNICATIONS STANDARD Version n.n Table of Contents 3. BUSINESS ENVIRONMENT Objectives Participants Between Providers and Adjudicators... 2 iii
4
5 TELECOMMUNICATIONS STANDARD Version n.n 3 BUSINESS ENVIRONMENT 3.1 Objectives The NCPDP Telecommunication Standard Implementation Guide (Version D and above) is intended to meet two needs within the pharmacy drug claim industry: 1. to provide practical guidelines for software developers throughout the industry as they implement the Version D and above Standard, and 2. to ensure a consistent implementation of the Version D and above Standard. This version of the standard facilitates a specific type of business communication among diverse parties within the third party environment. To do this successfully, it must accomplish the following goals: Support the needs of a wide base of potential users, Maximize use of existing relevant standards wherever possible, Be flexible enough to change as needs and technology change, Be unambiguous, and Be easy to implement by carriers and vendors. 3.2 Participants The NCPDP Telecommunication Standard Implementation Guide (Version D and above) supports prescription claim transactions, services, and reportings between the following industry participants: Between Providers and Adjudicators, and Between Adjudicators (aka Payer-to-Payer) Between these entities and Switches/Intermediaries as determined by business need The NCPDP Telecommunication Standard Implementation Guide facilitates the exchange of information supporting REMS (Risk Evaluation & Mitigation Strategies) operations, PDMP (Prescription Drug Monitoring Program) reporting, and general communications between the following participants: Between Providers and REMS Administrators Between Providers and PDMP program administrators Between these entities and Switches and/or Intermediaries as determined by business need 1
6 Version n.n TELECOMMUNICATIONS STANDARD Between Providers and Adjudicators The communication between Providers and Adjudicators is two-way and the record layout for the transmitted claim and the response to the claim are defined by the Version D and above standard. The diagram below illustrates the typical business environments in which the NCPDP Telecommunication Standard Implementation Guide (Version D and above) is employed between providers and adjudicators. Figure Provider/Adjudicator Participants A Provider may be a retail pharmacy, mail order pharmacy, doctor s office, clinic, hospital, long-term care facility, or any other entity, which dispenses prescription drugs and submits those prescrip tions to a payer for reimbursement. A provider may be an entity that collects and reports information about prescribing, dispensing, and consumption of dangerous or abusable drugs or products such as a grocery store or convenience store. The Adjudicator (hereinafter referred to as the Processor ) is often a third-party administrator of prescription drug programs on behalf of insurers. The Adjudicator also may be an insurer, a governmental program or any other entity, which receives prescription drug claims, makes a decision regarding the level of reimbursement to the provider, and transmits a response to the provider. An adjudicator may be an entity that receives reporting information, record keeping, auditing, or authorizations of services, such as an entity performing drug utilization review reporting or reporting related to abusable products. 2
7 TELECOMMUNICATIONS STANDARD Version n.n Providers may choose to transmit certain prescription drug claims to an Intermediary. Intermediaries receive claims from switches or providers, perform editing/messaging and then either pass the claims to the appropriate switch or adjudicator or return (reject) claims to the providers. The reply from the adjudicator also may pass to an intermediary for editing and messaging on its return to the provider. Providers may choose to transmit claims to an intermediary for a number of reasons, including the following: Consolidated provider reporting Inventory tracking Consolidated claim editing and messaging The Switch also receives transactions from providers and intermediaries as claims pass from providers to adjudicators. Switching companies accept transactions, optionally perform format conversions, and optionally perform pre-edits or post-edits., The switch passes the transaction to the appropriate processor. The reply from the processor also may pass through the switch on its return to the provider. (In some instances the switch returns an approved response if the transaction is for a cash prescription.) Providers utilize the services of a switch for a number of reasons, including the following: Capture of data Pre and/or post editing A processor may not support Dial-Up communications All transactions can be transmitted to one central point, the Switch Increased reliability of communications 3
8
National Council for Prescription Drug Programs
National Council for Prescription Drug Programs White Paper The Proper Use of the NCPDP Telecommunication Standard Version D.0 as it applies to the Implementation of Medicaid Reimbursement Methodologies
More informationUpstream Reporting of Copay Assistance Issues Brief
Upstream Reporting of Copay Assistance Issues Brief National Council for Prescription Drug Programs 9240 East Raintree Drive Scottsdale, AZ 85260 Phone: (480) 477-1000 Fax: (480) 767-1042 e-mail: ncpdp@ncpdp.org
More informationemedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards
STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards December 18, 2003 Version 1.7 December 2003 Computer Sciences
More informationemedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards
STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards December 06, 2005 Version 1.18 December 2005 Computer
More informationemedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards
STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards July 30, 2010 Version 1.33 July 2010 Computer Sciences
More informationNCPDP Electronic Prescribing Standards
NCPDP Electronic Prescribing Standards May 2014 1 What is NCPDP? An ANSI-accredited standards development organization. Provides a forum and marketplace for a diverse membership focused on health care
More informationX12N/005010X220A1Benefit Enrollment and Maintenance (834) and the X12N/005010X221A1 Health Care Claim Payment/Advice (835) QUESTIONS AND ANSWERS
X12N/005010X220A1Benefit Enrollment and Maintenance (834) and the X12N/005010X221A1 Health Care Claim Payment/Advice (835) QUESTIONS AND ANSWERS Version 1.2 March 2017 National Council for Prescription
More informationTexas Vendor Drug Program Pharmacy Provider Procedure Manual
Texas Vendor Drug Program Pharmacy Provider Procedure Manual System Requirements May 2018 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual. ` Table
More information2019 Transition Policy
2019 Number: 5.8 Prescription Drug Replaces: 5.8 v.2018 Cross 5.1.2 Transition Fill Monitoring Procedure References: Purpose: To provide guidance on the transition process for new or current Plan members
More informationSubject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5.
P R O V I D E R B U L L E T I N B T 2 0 0 3 6 1 S E P T E M B E R 1 9, 2 0 0 3 To: All Pharmacy Providers Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription
More informationPennsylvania PROMISe Companion Guide
Pennsylvania PROMISe Companion Guide NCPDP Version D.0 September 2010 Version 1.0 This page is left intentionally blank September 2010 Table of Contents Overview... 1 Revisions to the Companion Guide...
More informationE-PRESCRIBING SERVICES TERMS
E-PRESCRIBING SERVICES TERMS Certain software licensed by Allscripts Healthcare, LLC ( Allscripts ) may allow Client to access E- Prescribing Services (as defined below) to route prescriptions, access
More informationLife Journey of a Claim
Full Cycle of the Argus System At the Doctor s Office To the Pharmacy At the Pharmacy Entering the Claim The doctor prescribes medication for the patient. Life Journey of a Claim The doctor writes a prescription
More informationBest Practice Recommendation for
Best Practice Recommendation for Exchanging & Processing about Pharmacy Benefit Management Version 020915a Issue Date Version Explanation 10-20-2014 First Release 02-09-15 Clarify language under Health
More informationHarvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care
SCOPE: Harvard Pilgrim Health Care Medicare Advantage enrollees, their providers, and all HPHC Pharmacy, Customer Service and Appeals & Grievances Staff. OBJECTIVE: To efficiently provide new enrollees
More informationMagellan Complete Care of Virginia (MCC of VA) Provider Training. July 2017
Magellan Complete Care of Virginia (MCC of VA) Provider Training July 2017 A Managed Long Term Services and Supports Program On August 1, 2017, Magellan Complete Care of Virginia (MCC of VA) part of the
More information2012 Checklist for Community Pharmacy. Medicare Part D-Related Information
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 Checklist for Community Pharmacy Medicare Part D-Related Information Medicare Part D Valid Prescriber Identifiers For 2012, CMS will continue to permit the
More informationNCPDP VERSION 5.1 REQUEST PAYER SHEET
NCPDP VERSION 5.1 REQUEST PAYER SHEET Payer Name: WellPoint Pharmacy Revised Date: 12/11/2005 Management Processor: WellPoint Pharmacy Switch: All Management Effective as of: 1/1/2006 Version/Release #:
More informationHarvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care
SCOPE: Medicare Advantage enrollees, their providers, and all HPHC Pharmacy, Customer Service and Appeals & Grievances Staff. OBJECTIVE: To avoid interruption in therapy, timely access to a temporary supply
More informationNCPDP EMERGENCY PREPAREDNESS INFORMATION
NCPDP EMERGENCY PREPAREDNESS INFORMATION VERSION 1.4 This document provides resource information for the pharmacy industry for a declared emergency. National Council for Prescription Drug Programs 9240
More informationMartin s Point Generations Advantage Policy and Procedure Form
Martin s Point Generations Advantage Policy and Procedure Form Policy #: PartD.923 Effective Date: 4/16/10 Policy Title: Part D Transition Policy Section of Manual: Medicare Prescription Drug Benefit Manual
More informationCommunity Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018
Title: and H2034 HMO-SNP 2018 Policy Identifier: PA - Pharmacy Effective Date: 20180101 Scope: Organization Wide Family Care PACE Partnership Waukesha Day Center HUD (Housing and Urban Development) Department:
More informationCHIPS Rules and Administrative Procedures Effective January 1, 2018
CHIPS Rules and Administrative Procedures Effective January 1, 2018 Copyright 2017 by The Clearing House Payments Company L.L.C. All rights reserved. RULES GOVERNING THE CLEARING HOUSE INTERBANK PAYMENTS
More informationInformation Maintained by the Office of Code Revision Indiana Legislative Services Agency IC Chapter 22. Pharmacy Audits
Information Maintained by the Office of Code Revision Indiana Legislative Services Agency IC 25-26-22 Chapter 22. Pharmacy Audits IC 25-26-22-1 Definitions applicable to chapter Sec. 1. The definitions
More informationMedicare Transition POLICY AND PROCEDURES
Medicare Transition POLICY AND PROCEDURES POLICY The Plan will maintain an appropriate transition process, consistent with 42 CFR 423.120(b)(3), Chapter 6 of the Medicare Prescription Drug Benefit Manual
More informationNCPDP Version 5 Request Payer Sheet
NCPDP Version 5 Request Payer Sheet NCPDP Rev.04.16.02 General Information Payer Name: 4-D Pharmacy Benefits Plan Name/Group Name: 4-D Pharmacy Benefits Processor: Argus Payer Sheet Revision Effective
More informationWELCOME TO OUR OFFICE. Patient s Name: Today s Date: First Middle Last. Home Address: City: State: Zip: Telephone: Home ( ) Cellular: ( ) Work: ( )
WELCOME TO OUR OFFICE Patient s Name: Today s Date: First Middle Last Home Address: City: State: Zip: Telephone: Home ( ) Cellular: ( ) Work: ( ) Email: Personal Work DOB: Age: SSN#: Ethnic Background:
More informationNCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017
NCPDP Update Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard May 23, 2017 Catherine C Graeff CEO, Sonora Advisory Group, LLC Active in NCPDP since 1988 - as a member,
More information2019 Transition Policy and Procedure
2019 Transition Policy and Procedure POLICY Steward Health Choice Generations (SHCG) provides a Part D drug transition process in order to prevent enrollee medication coverage gaps. SHCG s transition process
More informationWhat Regulatory Requirements are Responsible for the Transactions Standards?
Versions 5010 Why the Change? 99% of Medicare Part A and 96% of Part B Claims are submitted electronically New Accreditations standards adopted with Electronic Medical Records must align with the submitted
More informationEnrollment Form for ENTRESTO Central Patient Support Program
Enrollment Form for ENTRESTO Central Patient Support Program Dear Health Care Professional, Thank you for choosing ENTRESTO Central Patient Support Program. Please take a moment to read through the instructions
More informationPURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES
PURPOSE OF THE POLICY The purpose of this policy is to describe Health Alliance s process for transitions and ensure that continued drug coverage is provided to new and current Part D members. The transition
More informationIndiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07)
Indiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07) Overview Pharmacy Benefit Manager Pharmacy Claims Processor Preferred Drug List Pharmacist Override
More informationOTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.
NCPDP VERSION D CLAIM BILLING/CLAIM REBILL REQUEST CLAIM BILLING/CLAIM REBILL PAYER SHEET ** Start of Request (B1/B3) Payer Sheet ** GENERAL INFORMATION Payer Name: AmeriHealth Caritas Louisiana Date:
More informationOTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.
NCPDP VERSION D CLAIM BILLING/CLAIM REBILL REQUEST CLAIM BILLING/CLAIM REBILL PAYER SHEET ** Start of Request (B1/B3) Payer Sheet ** GENERAL INFORMATION Payer Name: Community Health Choices Date: 09/21/2017
More informationK A R A N J O HA R, M.D.
P: : REGISTRATION FORM - MAJOR MEDICAL Last Name: First and Middle Name: Social Security #: Birthdate: Age: Sex: F M Marital Status: M S D W Home Address: City: State: Zip: *Does the above address, match
More informationIntegrated Prescription Management (IPM)/ PharmAvail Benefit Management Payor Specification Sheet
Integrated Prescription anagement (IP)/ PharmAvail Benefit anagement Payor Specification Sheet BIN #: 014658, 610114 Effective Date: 03/01/2011 States: National Destination: Integrated Prescription anagement
More informationElite Visa Benefit Card Frequently Asked Questions
What is the Elite Visa Benefit Card? The Elite Benefit Card is a stored-value card that simplifies the process of paying for qualified health flexible spending account (FSA) expenses. As an alternative
More information**** Does the above address, match the address on your State Identification Card? Yes No *****
Kenneth B. Chapman, M.D. Kiran V. Patel, M.D. Keyvan Jahanbakhsh, M.D. Uel J. Alexis, M.D. Cameron Marshall, M.D. Brian Maloney, M.D. Last Name First Name: SS# Birth : / / Age Sex: F M Marital Status:
More informationRe: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]
January 25, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4180-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Modernizing
More informationNCPA summary of Part D Final Rule for contract year NCPA advocacy at work
NCPA summary of Part D Final Rule for contract year 2019 The Centers for Medicare and Medicaid Services ( CMS ) recently issued its final rule (the Final Rule ) to revise the Medicare Advantage and Part
More informationClaim Revenue Optimization- Atlantic
................................................................................................... Claim Revenue Optimization- Atlantic Pharmacy Technology Solutions April, 2014 Modify a Prescription
More informationReal-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions
Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions PBMI Annual Drug Benefit Conference March 6, 2017 PRESENTERS: Anthony Schueth, Point-of-Care Partners Julia
More informationPayer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs
Payer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs General information Prime Therapeutics LLC September 1, 2018 Plan Name BIN PCN BCBS of Texas Medicaid
More informationClaim Revenue Optimization - Ontario
................................................................................................... Claim Revenue Optimization - Ontario Pharmacy Technology Solutions January, 2015 Modify a Prescription
More informationMedicare Part D Transition Policy
Medicare Part D Transition Policy Transition Policy for New and Current Enrollees of our Medicare Part D Prescription Drug Plan PURPOSE: Simply Healthcare Plans, Inc. must maintain an appropriate transition
More informationTELECOMMUNICATION VERSION 5 QUESTIONS, ANSWERS AND EDITORIAL UPDATES
TELECOMMUNICATION VERSION 5 QUESTIONS, ANSWERS AND EDITORIAL UPDATES DOCUMENTATION November 2Ø1Ø National Council for Prescription Drug Programs 924Ø East Raintree Drive Scottsdale, AZ 8526Ø Phone: (48Ø)
More informationI. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:
I. PURPOSE The purpose of the Policy and Procedure is to ensure necessary continuity of treatment and to provide adequate time and transition process to introduce the enrollee and their prescribing physician
More informationTELECOMMUNICATION VERSION D AND ABOVE QUESTIONS, ANSWERS AND EDITORIAL UPDATES
TELECOMMUNICATION VERSION D AND ABOVE QUESTIONS, ANSWERS AND EDITORIAL UPDATES DOCUMENTATION National Council for Prescription Drug Programs 924Ø East Raintree Drive Scottsdale, AZ 8526Ø Phone: (48Ø) 477-1ØØØ
More informationThe Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers
CONTEMPORARY SUBJECT The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Pharmacy Benefit: Implications for Health Plans, PBMs, and Providers DANIEL C. WALDEN, JD, and ROBERT
More informationDr. Sarah Y. Vinson s Practice Policies
Dr. Sarah Y. Vinson s Practice Policies FEE SCHEDULE: $230 50 minute psychotherapy and/or psychopharmacology appt. $450 2 hour initial intake appt. $155 30 minute phone, Skype or in-person appt.; $125
More informationFrequently Asked Questions by Plan Members Who Require Special Authorization for Their Drugs
Frequently Asked Questions by Plan Members Who Require Special Authorization for Their Drugs 1. What is Special Authorization (SA)? Your drug plan may designate a drug as Special Authorization (SA) Required.
More informationCh. 358, Art. 4 LAWS of MINNESOTA for
Ch. 358, Art. 4 LAWS of MINNESOTA for 2008 14 paragraphs (c) and (d), whichever is later. The commissioner of human services shall notify the revisor of statutes when federal approval is obtained. ARTICLE
More informationPharmacy Provider Enrollment Application
1. Application Date 11/28/2018 New Pharmacy Re-enrollment Vendor # 2. Applicant Name Of Pharmacy (Doing Business As) ABC Pharmacy Legal contractor name ABC Pharmacy, Inc Telephone Fax Email Change of Ownership
More information2012 Medicare Part D Transition Process for contracts H3864 & H4754:
2012 Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6, Essentials Rx 14, Essentials Rx 15, Essentials Rx 16, Premier Rx 7, Explorer Rx 1, Explorer Rx 2, and Explorer Rx 4
More informationAll Pharmacy Providers and Prescribing Practitioners. Subject: Significant Changes to Pharmacy Claims Processing
P R O V I D E R B U L L E T I N BT200260 NOVEMBER 18, 2002 To: All Pharmacy Providers and Prescribing Practitioners Subject: Significant Changes to Pharmacy Claims Processing Note: The information in this
More information2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:
2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),
More informationElectronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward
Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward Friday, April 20 th from 11:45am to 12:45am Marc Nyarko, Humana Bruce Wilkinson, CVS Caremark Roger Pinsonneault,
More informationemedny New York State Department of Health Office of Health Insurance Programs Pended Claims Report:
emedny New York State Department of Health Office of Health Insurance Programs Pended Claims Report: Specification Version: 1.2 Publication: 10/26/2016 Trading Partner: emedny NYSDOH 1 emedny Pended Claims
More informationBraeburn Patient Assistance Program Application
The provides Probuphine at no cost to patients that do not have healthcare coverage and/or adequate coverage for Probuphine. All applications are reviewed on a case-by-case basis to support the Braeburn
More informationFormulary Services EULA
Formulary Services EULA Formulary Services. Allscripts is reliant on Surescripts in facilitating the provision of the Formulary Services described in Schedule A (the Formulary Services Terms ). If Surescripts
More information2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018
Policy Title: Department: Policy Number: 2018 Transition Fill Policy & Procedure Pharmacy CH-MCR-PH-01 Issue Day: Effective Dates: 01/01/2018 Next Review Date: 04/01/2018 Revision Dates: 05/19/2016 11/14/2016
More informationHOW TO REGISTER ON THE OECD ESOURCING PORTAL
HOW TO REGISTER ON THE OECD ESOURCING PORTAL Bidder - User Guide OECD all rights reserved Create your Organisation Profile Access the esourcing Portal following the link: https://oecd.bravosolution.com
More informationSupplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective
Supplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective 10-1-2017 Date: 03/09/2017 Table of Contents 1 BACKGROUND... 1 2 PURPOSE... 2 3 REPORT NAME & PURPOSE... 2 4 REPORT
More informationOTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.
NCPDP VERSION D CLAIM BILLING/CLAIM REBILL REQUEST CLAIM BILLING/CLAIM REBILL PAYER SHEET ** Start of Request (B1/B3) Payer Sheet ** GENERAL INFORMATION Payer Name: San Francisco Health Plan Date: 04/16/2013
More informationANTI-FRAUD PLAN INTRODUCTION
ANTI-FRAUD PLAN INTRODUCTION We recognize the importance of preventing, detecting and investigating fraud, abuse and waste, and are committed to protecting and preserving the integrity and availability
More informationCHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT
CHAPTER 58-29E PHARMACY BENEFITS MANAGEMENT 58-29E-1. Definition of terms. Terms used in this chapter mean: (1) "Covered entity," a nonprofit hospital or medical service corporation, health insurer, health
More informationStep 3: To assist us in determining the available list of pharmacy plans to be contracted, please complete the enclosed Insurance Payer List.
BillingScripts Rx Initial Enrollment Packet Thank you for choosing BillingScripts Rx for your pharmaceutical billing and funding services. This Initial Enrollment Packet contains instructions and forms
More informationPrescription Drug Event (PDE) Data: Source and Processing
Prescription Drug Event (PDE) Data: Source and Processing Barbara Frank, M.S., M.P.H. Director of Workshops, Outreach, & Research University of Minnesota Frequently Repeated Acronyms CMS Centers for Medicare
More informationPEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed
Subject: Transition Process for Medicare Part D Approval Group: Pharmacy Management Group Signed By: Ellen Garcia, Executive Director Policy Number: CP5500.120 Policy Owner: Health Plan Operations Manager
More informationPrior Authorization between Prescribers and Processors for the Pharmacy Benefit
Prior Authorization between Prescribers and Processors for the Pharmacy Benefit Tony Schueth Lynne Gilbertson Panel 4 February 19, 2014 Electronic Prior Authorization Process for the Pharmacy Benefit using
More informationArchived SECTION 17 - CLAIMS DISPOSITION. Section 17 - Claims Disposition
SECTION 17 - CLAIMS DISPOSITION 17.1 ACCESS TO REMITTANCE ADVICES...2 17.2 INTERNET AUTHORIZATION...3 17.3 ON-LINE HELP...3 17.4 REMITTANCE ADVICE...3 17.5 CLAIM STATUS MESSAGE CODES...7 17.5.A FREQUENTLY
More informationSTATE OF NEW JERSEY. SENATE, No th LEGISLATURE. Sponsored by: Senator NIA H. GILL District 34 (Essex and Passaic)
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Senator NIA H. GILL District (Essex and Passaic) SYNOPSIS Regulates pharmacy benefits management companies. CURRENT
More informationPharmacy Billing and Reimbursement
FSHP Disclosure Pharmacy Billing and Tara L McNulty RPhT, CPhT I, Tara McNulty, do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies
More informationemedny Prospective Drug Utilization Review/ Electronic Claims Capture and Adjudication ProDUR/ECCA Provider Manual
STATE OF NEW YORK DEPARTMENT OF HEALTH emedny Prospective Drug Utilization Review/ Electronic Claims Capture and Adjudication ProDUR/ECCA Provider Manual May 16, 2007 Version 1.21 May 2007 Computer Sciences
More informationAonLine Service Agreement Effective July 19, By logging into AonLine, user agrees to these terms and conditions (T&C):
AonLine Service Agreement Effective July 19, 2014 By logging into AonLine, user agrees to these terms and conditions (T&C): 1. Definitions. For purposes of this Agreement, the following definitions shall
More informationAssure Card Deferred Reimbursement. Making the most of your benefits for plan members and their dependants
Assure Card Deferred Reimbursement Making the most of your benefits for plan members and their dependants Welcome to Assure Paying for your prescriptions has never been so easy The Assure Card Deferred
More informationPBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS*
PBM MODEL A A MODEL ACT RELATING TO PHARMACY BENEFIT MANAGERS* Whereas: It is essential to understand the drivers and impacts of prescription drug costs, and transparency is the first step toward that
More informationCompensation and Reimbursement
492 Pharmacy Management: Compensation and Reimbursement Positions Compensation and Reimbursement Revenue Cycle Compliance and Management (1710) To encourage pharmacists to serve as leaders in the development
More informationHIPAA Implementation: The Case for a Rational Roll-Out Plan. Released: July 19, 2004
HIPAA Implementation: The Case for a Rational Roll-Out Plan Released: July 19, 2004 1 1. Summary HIPAA Administrative Simplification, as it is currently being implemented, is increasing complexity and
More information80th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 572
0th OREGON LEGISLATIVE ASSEMBLY--0 Regular Session Senate Bill Sponsored by Senator HANSELL, Representative SMITH G; Senator LINTHICUM (at the request of Oregon State Pharmacy Coalition) (Presession filed.)
More information1 SB By Senators Beasley, Smitherman, Irons, Bussman and Ross. 4 RFD: Health. 5 First Read: 12-APR-11. Page 0
1 SB390 2 124198-2 3 By Senators Beasley, Smitherman, Irons, Bussman and Ross 4 RFD: Health 5 First Read: 12-APR-11 Page 0 1 124198-2:n:03/21/2011:MCS/ll LRS2010-4156R1 2 3 4 5 6 7 8 SYNOPSIS: Existing
More informationNCPDP VERSION D CLAIM BILLING
NCPDP VERSION D CLAI BILLING REQUEST CLAI BILLING SECONDARY PAYER IS EDICARE D BASED ON OTHER PAYER PAID PAYER SHEET GENERAL INFORATION Payer Name: Envolve Pharmacy Solutions Date: Plan Name/Group Name:
More informationEmployers Forum of Indiana and epa. March 23, 2016
Employers Forum of Indiana and epa March 23, 2016 Copyright Copyright 2016 by 2016 Surescripts, by Surescripts, LLC. All LLC. rights All reserved. rights reserved. Prior authorization, the problem we are
More informationLEGISLATURE 2017 BILL. reporting by manufacturers and providing a penalty.
0-0 LEGISLATURE LRB-/ 0 AN ACT to create.0 of the statutes; relating to: prescription drug cost reporting by manufacturers and providing a penalty. Analysis by the Legislative Reference Bureau This bill
More informationInsightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.
Insightsfeature Managing Specialty Drug Spend Under the Medical Benefit Innovations and Automation for More Effective Management March 30, 2017 The Less-Visible Part of Specialty Spend By most estimates,
More information1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.
1 INSURANCE SECTION : This section contains information about the cardholder and their plan identification. 1 ID of Cardholder Required. Enter the recipient s 13 digit Medicaid ID. 2 Group ID Not Required.
More informationRenee Gravalin, Partner
Experience the Eide Bailly Difference 340B Drug Program Renee Gravalin, Partner rgravalin@eidebailly.com 701.799.5449 Agenda Proposed Changes 1 Experience the Eide Bailly Difference Created in 1992 to
More informationDEMOGRAPHICS & BILLING INFORMATION
Jeffrey B. Russell, MD, FACOG, Director Board Certified Reproductive Endocrinology & Infertility 4745 Ogletown-Stanton Road Suite 111 Newark, DE 19713 Tel: 302-738-4600 Fax: 302-738-3508 556 South DuPont
More informationBraeburn Access Program Probuphine (buprenorphine) Implant Patient Buy and Bill Order Form
Braeburn Access Program Probuphine (buprenorphine) Implant Patient Buy and Bill Order Form Section 1: Patient Information Please complete all fields on the form and fax to 1-866-441-4091 or email info@braeburnaccessprogram.com
More information340B Drug Program Compliance: Focus on Disproportionate Hospitals
340B Drug Program Compliance: Focus on Disproportionate Hospitals Part II: 340B Drug Program Compliance: Pharmacy Operations and the DSH January 29, 2014 1 Faculty Stephen J. Weiser, JD, LLM Director 312-403-4284
More informationTexas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018
Texas Vendor Drug Program Pharmacy Provider Procedure Manual Coordination of Benefits Effective Date February 2018 The Pharmacy Provider Procedure Manual (PPPM) is available online at txvendordrug.com/about/policy/manual.
More informationPATIENT REGISTRATION FORM
Today s Date / / PATIENT REGISTRATION FORM PATIENT INFORMATION Patient Name Last First Middle Is this your legal name? If not, what is your legal name? Birthdate Age Sex q YES q NO / / q M q F q T Street
More information2018 Medicare Part D Transition Policy
Regulation/ Requirements Purpose Scope Policy 2018 Medicare Part D Transition Policy 42 CFR 423.120(b)(3) 42 CFR 423.154(a)(1)(i) 42 CFR 423.578(b) Medicare Prescription Drug Benefit Manual, Chapter 6,
More informationGERALD (JERRY) LEWANDOWSKI. BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036
Curriculum Vitae GERALD (JERRY) LEWANDOWSKI BERKELEY RESEARCH GROUP, LLC 1800 M Street NW, Second Floor Washington, DC 20036 Direct: 202.480.2643 Mobile: 202.258.2669 jlewandowski@thinkbrg.com Jerry Lewandowski
More informationIEHP Medicare DualChoice Program Pharmacy Program Manual
IEHP Medicare DualChoice Program Pharmacy Program Manual Claim processing information Patient Location Code: Please enter the appropriate Patient Location Code for each claim. Incorrect patient location
More informationChristina Agustin, MD Board Certified in Adult Psychiatry 1 Lake Bellevue Drive, Suite 101 Bellevue, WA Phone Fax:
Christina Agustin, MD Board Certified in Adult Psychiatry 1 Lake Bellevue Drive, Suite 101 Bellevue, WA 98005 Phone 425-301-9869 Fax: 866-546-1618 Welcome to my practice. I look forward to meeting with
More informationArizona Department of Health Services Division of Behavioral Health Services PROVIDER MANUAL NARBHA Edition
Arizona Department of Health Services Division of Behavioral Health Services PROVIDER MANUAL NARBHA Edition Section 6.2 6.2.1 Introduction 6.2.2 References 6.2.3 Scope 6.2.4 Did you know? 6.2.5 Definitions
More informationUNIVERSITY - INDUSTRY SPONSORED RESEARCH AGREEMENT
UNIVERSITY - INDUSTRY SPONSORED RESEARCH AGREEMENT THIS SPONSORED RESEARCH AGREEMENT (the Agreement ), effective this day of, 20 ( Effective Date ) is made by and between Northeastern University, a non-profit
More informationSPRINT CLOUDCOMPUTE INFRASTRUCTURE SERVICES PRODUCT ANNEX
SPRINT CLOUDCOMPUTE INFRASTRUCTURE SERVICES PRODUCT ANNEX The following terms and conditions, together with the Sprint Standard Terms and Conditions for Communication Services ( Standard Terms and Conditions
More information